AR009338A1 - MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION - Google Patents
MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITIONInfo
- Publication number
- AR009338A1 AR009338A1 ARP970103874A AR009338A1 AR 009338 A1 AR009338 A1 AR 009338A1 AR P970103874 A ARP970103874 A AR P970103874A AR 009338 A1 AR009338 A1 AR 009338A1
- Authority
- AR
- Argentina
- Prior art keywords
- vitamin
- dose composition
- unit dose
- multivitaminic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Una composicion de dosis de unidad multivitamínica que comprende: Vitamina A: 1500 IU; Vitamina B1: 6 mg; Vitamina B2: 6 mg; Niacina: 10 mg; Niacinamida:30 mg; Vitamina B5: 45 mg; Vitamina B6: 6 mg; Vitamina B12: 90 mcg; Biotina: 21 mcg; Acido Parabenzoico: 35 mg; Vitamina C: 50 mg; Vitamina D: 25 IU; VitaminaE di alfa: 50 IU; Vitamina K: 0,5 mg; Acido folico: 125 mcg; Inositol: 10 mg; Colino: 35 mg; Caroteno beta: 825 IU; bioflavoroida: 75 mg. La composicionse usa para la fabricacion de unacomposicion de dosis de unidad multivitamínica que provee vitaminas a una persona con necesidad de ellas.A multivitamin unit dose composition comprising: Vitamin A: 1500 IU; Vitamin B1: 6 mg; Vitamin B2: 6 mg; Niacin: 10mg; Niacinamide: 30mg; Vitamin B5: 45 mg; Vitamin B6: 6 mg; Vitamin B12: 90 mcg; Biotin: 21 mcg; Parabenzoic Acid: 35 mg; Vitamin C: 50 mg; Vitamin D: 25 IU; Vitamin E di alpha: 50 IU; Vitamin K: 0.5 mg; Folic acid: 125 mcg; Inositol: 10 mg; Choline: 35 mg; Beta carotene: 825 IU; bioflavoroide: 75 mg. The composition is used for the manufacture of a multivitamin unit dose composition that provides vitamins to a person in need of them.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70330196A | 1996-08-26 | 1996-08-26 | |
US74455096A | 1996-11-06 | 1996-11-06 | |
US83336597A | 1997-04-04 | 1997-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR009338A1 true AR009338A1 (en) | 2000-04-12 |
Family
ID=27418756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970103874 AR009338A1 (en) | 1996-08-26 | 1997-08-26 | MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR009338A1 (en) |
AU (1) | AU4162297A (en) |
CO (1) | CO4900029A1 (en) |
ID (1) | ID19355A (en) |
MA (1) | MA24308A1 (en) |
WO (1) | WO1998008522A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7951844B2 (en) | 2007-04-05 | 2011-05-31 | J-Oil Mills, Inc. | Tranquilizer and functional food |
CN104027339B (en) * | 2014-06-12 | 2017-01-18 | 王淑芳 | Vitamin composition and application thereof in regulating ovarian function |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4432975A (en) * | 1981-04-13 | 1984-02-21 | Icn Pharmaceuticals, Inc. | Process for introducing vitamin B-12 into the bloodstream |
US4945083A (en) * | 1986-06-03 | 1990-07-31 | Jansen Jr Christian J | Safe oral folic-acid-containing vitamin preparation |
US5308627A (en) * | 1990-08-07 | 1994-05-03 | Umbdenstock Jr Anthony J | Nutritional supplement for optimizing cellular health |
US5514382A (en) * | 1994-10-17 | 1996-05-07 | Sultenfuss; Sherry | Daily vitamin and mineral supplement for women |
-
1997
- 1997-08-25 CO CO97048862A patent/CO4900029A1/en unknown
- 1997-08-26 ID IDP972975A patent/ID19355A/en unknown
- 1997-08-26 MA MA24777A patent/MA24308A1/en unknown
- 1997-08-26 AU AU41622/97A patent/AU4162297A/en not_active Abandoned
- 1997-08-26 AR ARP970103874 patent/AR009338A1/en unknown
- 1997-08-26 WO PCT/US1997/014968 patent/WO1998008522A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU4162297A (en) | 1998-03-19 |
MA24308A1 (en) | 1998-04-01 |
ID19355A (en) | 1998-07-02 |
CO4900029A1 (en) | 2000-03-27 |
WO1998008522A1 (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gloth et al. | Can vitamin D deficiency produce an unusual pain syndrome? | |
US5770215A (en) | Multivitamin/vascular occlusion inhibiting composition | |
DE69332777D1 (en) | MULTIVITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT | |
AR004108A1 (en) | USE OF 4- (4-FLUOROBENCILAMINO) -2-AMINO-1-ETOXICARBONYLAMINOBENZENE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE PROPHYLAXIS AND SANTA CRUISE OF ACUTE INSUFFICIENCY AND CRANE LAUR THE TREATMENT OF NEURODEGENRATIVE DISEASES | |
BR0114080A (en) | Dietary supplement, use thereof, method to assist in the prevention or treatment of oxidative damage, food, and methods for manufacturing the same, and to improve or increase the work output of an animal. | |
MX9301787A (en) | NUTRITIONAL LIQUID PRODUCT FOR ENTERAL FEEDING. | |
NZ516101A (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
MX9307884A (en) | APPLICATION OF CARBAMAZEPINE OR OXCARBAMAZEPINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF NEUROLOGICAL INJURIES LINKED TO TRAUMATISMS. | |
ES2092275T3 (en) | NUTRITIVE PRODUCT FOR PEOPLE WHO RECEIVE KIDNEY DIALYSIS. | |
BR9810547A (en) | Absorption of minerals by intestinal cells | |
CY1112547T1 (en) | Means Containing Folic Acid, Vitamin B6 And Vitamin B12, And Their Use | |
ES2185816T3 (en) | FORMS OF PHARMACEUTICAL DOSAGE FOR THE ORAL ROUTE, WHICH INCLUDE AN INHIBITING AGENT OF THE PUMP OF PROTONS AND A PROCEDURAL AGENT. | |
US5883086A (en) | DHEA-containing nutritional supplement | |
ATE189400T1 (en) | BONE GROWTH-PROMOTING COMPOSITION | |
BR9609413A (en) | Dietary and pharmaceutical formulations for the prophylaxis and treatment of gastrointestinal disorders | |
ES2177642T3 (en) | USE OF CERTAIN DERIVATIVES OF METHANOPHYPHOSPHONIC ACID TO PREVENT DETACHMENT AND MIGRATION OF PROTESIS. | |
DE69716261D1 (en) | MEDICINAL PREPARATION CONSISTING OF RHINE OR DIACERHEIN WITH IMPROVED BIOV AVAILABILITY | |
WO1995031991A3 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
AR009338A1 (en) | MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION | |
AR026254A1 (en) | THE USE OF A CONTROLLED RELEASE PREPARATION FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE THE DOSE OR SYSTEM EXPOSURE OF A PHARMACO THAT INHIBITS PHOSPHODESTERASE 4 | |
SE8403659L (en) | SYNERGISTIC PHARMACEUTICAL COMPOSITIONS | |
ES2062138T3 (en) | USE OF 5'-DEOXI-5'-METHYLTHIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR HAIR GROWTH IN ADOLESCENT SUBJECTS OF CALVICIE. | |
ES2105219T3 (en) | A COMPOSITION CONTAINING IRON FOR THE PREVENTION OF ANEMIA AND A METHOD TO PRODUCE SUCH COMPOSITION. | |
Pandey et al. | Role of vitamin D in iron metabolism, a pilot study | |
CY1106961T1 (en) | USE OF HOMOCYCINE PLASMA CONTENTS REDUCTION FACTORS TO REDUCE THE RISK OF THOMBOEVOLOGICAL PARENERGY PROCESSED THROUGH |